IL6 and neoplasm: This further suggests that IL-6 plays a critical role as a pro-inflammatory cytokine in the tumour microenvironment [22] and its elevated levels in CC patients may reflect ongoing chronic inflammation, which promotes tumour growth, angiogenesis and immune evasion [14].